Abstract:Background: Polycystic ovarian syndrome (PCOS) is a commonly occurring reproductive disorder among the reproductive-aged women. Its global occurrence varies based on diagnostic guidelines, ethnicities, and locations of concern. Insulin resistance (IR) is commonly observed around 65-70% of women diagnosed with PCOS, representing a prevalent association. Consequently, the study was designed with an objective of illustrating the effect of insulin on mural and cumulus granulosa cells (GCs) of PCOS patients in comparison to normal ovulating women. Methodology: This study is a case-control design, wherein a total of 80 participants were recruited meeting criterion of inclusion and exclusion, divided into 8 groups with each group consisting of 10 samples. The process involves the isolation and culturing of mural granulosa cells (MGC) and cumulus granulosa cells (CGC) with and without exposure to insulin. The proteins released by untreated GCs and insulin-treated GCs were extracted, and complex protein mixtures were digested with trypsin, followed by tandem mass spectrometry analysis and data processing using bioinformatics. Results: We found 595 proteins in both control and PCOS samples, of which 310 were contributed by MGCs and 285 by CGCs. The PCOS MGCs expressed 20%, both the normal MGCs and CGCs have equal representation of 16% by each, whereas the PCOS CGCs proteins contributed 15% of the total of the proteomic expression. However, the poor expression observed with the Insulin exposure, the Insulin treated PCOS CGCs contributes 13%, PCOS MGCs contributes 8%. The normal MGCs upon the Insulin treatment give 8% then and there only 4% of proteins expressed by normal CGCs after Insulin treatment. The Venn analysis widened on their precise expression topographies. The examination of strings exhibited important protein-protein interaction pathways. Conclusion: This is a pioneering investigation aimed to establish the link between hyperinsulinemia in localized follicular GCs and PCOS mechanisms by comparing them to control group. The examination of various attributes, mechanisms, and traits shown by genes and proteins in individuals with PCOS compared to control populations, alongside the investigation of the dynamics of these genes and proteins following exposure to insulin, holds promise for the formulation of novel hypotheses and strategies in the identification of new biomarkers.

Expression of insulin receptor substrate-1 in endometrium of patients with polycystic ovary syndrome combined with insulin resistance

Gly~(972) Arg polymorphism and expression of insulin receptor substrate 1 of endometria in patients with polycystic ovary syndrome with insulin resistance

Study of insulin concentration and its receptor expression on endometrium of polycystic ovary syndrome with normal level of OGTT

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

Expression of Protein IGF-I and Bcl-2 in Endometrium in PCOS Patients with Insulin Resistance

Clinical study of insulin resistance in women with polycystic ovary syndrome

Proteomic and bioinformatic analysis of human endometrium from polycystic ovarian syndrome with and without insulin resistance

Tyrosine Phosphorylation and Protein Expression of Insulin Receptor Substrate-2 in the Adipose Tissue from Patients with Polycystic Ovary Syndrome

The occurrence of insulin resistance and metabolic syndrome in polycystic ovary syndrome

Comprehensive Assessment the Expression of Core Elements Related to IGFIR/PI3K Pathway in Granulosa Cells of Women with Polycystic Ovary Syndrome

Insulin resistance in polycystic ovary syndrome associated with obesity

Expression of Leptin and Long Form of Leptin Receptors Messenger Ribonucleic Acid and Protein in Endometrium of Patients with Polycystic Ovary Syndrome

Endocrine and metabolizable characters of polycystic ovary syndrome patients

Association Between Serum Level of Interleukin-18 and Insulin Resistance in Women with Polycystic Ovary Syndrome

Analysis of IVF-ET outcomes in patients with polycystic ovarian syndrome with different level of Insulin resistance

[Autophosphorylation of Erythrocyte Insulin Receptors in Patients with Polycystic Ovary Syndrome].

Single nucleotide polymorphism of insulin degrading enzyme gene correlation with polycystic ovary syndrome

Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance

Effect of Diane Combined with Metformin on Expression of Insulin Receptor in Endometrium of Patients with Insulin-Resistant Polycystic Ovary Syndrome

Differential Gene Expression Analysis of Human Ovarian Follicular Cumulus and Mural Granulosa Cells Under the Influence of Insulin in IVF Ovulatory Women and Polycystic Ovary Syndrome Patients Through Network Analysis

Local Cortisol Elevation Contributes to Endometrial Insulin Resistance in Polycystic Ovary Syndrome.